Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies
- PMID: 21549089
Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies
Similar articles
-
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.Int J Dermatol. 2012 Oct;51(10):1234-6. doi: 10.1111/j.1365-4632.2011.05166.x. Epub 2012 Mar 14. Int J Dermatol. 2012. PMID: 22416995 No abstract available.
-
Combining traditional agents and biologics for the treatment of psoriasis.Semin Cutan Med Surg. 2005 Mar;24(1):37-45. doi: 10.1016/j.sder.2005.01.002. Semin Cutan Med Surg. 2005. PMID: 15900797 Review.
-
Childhood psoriasis: often favorable outcome.Prescrire Int. 2009 Dec;18(104):275. Prescrire Int. 2009. PMID: 20027717
-
A global approach to psoriatic patients through PASI score and Skindex-29.G Ital Dermatol Venereol. 2011 Feb;146(1):47-52. G Ital Dermatol Venereol. 2011. PMID: 21317856 Clinical Trial.
-
Vitamin D and systemic therapy.Cutis. 2002 Nov;70(5 Suppl):16-20. Cutis. 2002. PMID: 12467335 Review.
Cited by
-
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis.Clin Cosmet Investig Dermatol. 2013;6:75-80. doi: 10.2147/CCID.S42424. Epub 2013 Mar 14. Clin Cosmet Investig Dermatol. 2013. PMID: 23515267 Free PMC article.
-
Use of biologic agents in combination with other therapies for the treatment of psoriasis.Am J Clin Dermatol. 2014 Dec;15(6):467-78. doi: 10.1007/s40257-014-0097-1. Am J Clin Dermatol. 2014. PMID: 25373522 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical